CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) today announced the addition of Mr. Howard Pien to the Company’s Board of Directors. Mr. Pien has more than twenty years of experience in pharmaceutical operations gained at leading healthcare companies.
